8-K/A: CareCloud Boosts Revenue with Strategic Acquisitions

CareCloud, Inc. files an amendment detailing pro forma financial results following its acquisitions of Medsphere, RevNu, and Mesa, showing increased revenue and positive adjusted EBITDA.

Summary

• CareCloud, Inc. completed the acquisitions of Medsphere Systems Corporation, RevNu Medical Management, and Mesa, LLC.
• The Medsphere acquisition, effective August 22, 2025, involved a purchase price of $16.5 million, comprising $8.25 million in cash and $8.25 million payable to Medsphere's secured bank lender.
• The RevNu acquisition, effective April 1, 2025, involved quarterly payments of 20% of revenue for 42 months.
• The Mesa acquisition, effective February 27, 2025, included $40,000 in cash and quarterly payments of 21% of gross revenue for 36 months.
• Pro forma net revenue for the combined entities was $152.382 million for the year ended December 31, 2024, and $71.820 million for the six months ended June 30, 2025.
• Pro forma GAAP net income was $4.086 million for the year ended December 31, 2024, and $2.783 million for the six months ended June 30, 2025.
• Pro forma Adjusted EBITDA was $25.253 million for the year ended December 31, 2024, and $11.098 million for the six months ended June 30, 2025.
• Medsphere, prior to acquisition, faced substantial doubt about its ability to continue as a going concern, with defaulted notes payable and revolving loans totaling approximately $62.5 million as of June 30, 2025.
• Medsphere recorded a $5 million notes payable exit fee as of June 30, 2025, with an additional $5 million agreed to in August 2025, totaling $10 million in exit fees.
• Medsphere reported a net loss of $(16.872) million for the year ended December 31, 2024, and $(10.910) million for the six months ended June 30, 2025.

Sentiment

Score: 6

Explanation: While Medsphere's standalone financials are very negative, CareCloud's acquisition and the resulting pro forma financials show positive net income and EBITDA, suggesting a strategic, albeit complex, integration that could be beneficial. The acquisition of distressed assets can be value-accretive if managed well, but the underlying issues of Medsphere are significant.

Positives

• Pro forma net revenue for the combined entities reached $152.382 million for the year ended December 31, 2024, and $71.820 million for the six months ended June 30, 2025.
• Pro forma GAAP net income was positive, at $4.086 million for 2024 and $2.783 million for H1 2025.
• Pro forma Adjusted EBITDA was $25.253 million for 2024 and $11.098 million for H1 2025, indicating operational profitability after adjustments.
• CareCloud's acquisition of Medsphere resolves Medsphere's significant going concern issues and defaulted debt, potentially removing a distressed competitor from the market.

Negatives

• Medsphere, prior to acquisition, had substantial doubt about its ability to continue as a going concern, with defaulted notes payable and revolving loans of approximately $62.5 million as of June 30, 2025.
• Medsphere incurred a $5 million notes payable exit fee as of June 30, 2025, with an additional $5 million agreed to in August 2025, totaling $10 million in exit fees.
• Medsphere reported significant net losses: $(16.872) million for 2024 and $(10.910) million for H1 2025.
• Medsphere's goodwill was impaired by $5.104 million in 2024 due to declining revenues, lack of marketability, and decreased company value.
• Estimated revenue from customers who cancelled prior to the acquisitions ($3.592 million for 2024 and $113 thousand for H1 2025) is included in pro forma revenue but will not be generated by CareCloud.

Risks

• Medsphere, prior to its acquisition, faced substantial doubt about its ability to continue as a going concern due to insufficient cash and financing commitments to fund past due balances of its 2021 note payable and revolving loan, totaling approximately $62.5 million as of June 30, 2025.
• Medsphere was in default on its loan obligations, incurring an additional 2% interest per annum on top of the 10.8% base rate.
• The pro forma financial information includes estimated revenue from customers who cancelled their contracts prior to the acquisitions, which CareCloud will not generate, potentially overstating future revenue expectations based on these pro forma figures.
• The preliminary purchase price allocations are subject to revision as additional information becomes available and detailed valuations are completed, which could materially alter the recognized assets and liabilities.

Future Outlook

The filing indicates that Medsphere's management has agreed with its creditors to wind down the company, with the filing anticipated to occur before December 31, 2025. CareCloud's pro forma statements reflect the expected combined financial performance post-acquisition, integrating the acquired entities' operations.

Management Comments

• Our management uses adjusted EBITDA as a financial measure to evaluate the profitability and efficiency of our business model.
• We use this non-GAAP financial measure to assess the strength of the underlying operations of our business.
• Management has agreed with its creditors to wind down the Company, and the filing is anticipated to occur before December 31, 2025.
• Management is not currently aware of any matters that will have a material adverse effect on the financial position, results of operations or cash flows of the Company.

Industry Context

CareCloud's acquisitions of Medsphere, RevNu, and Mesa represent a strategic move to consolidate assets within the healthcare IT solutions sector. The acquisition of Medsphere, a company facing significant financial distress and a planned wind-down, suggests an opportunistic purchase of a competitor's assets, potentially at a favorable valuation, to expand CareCloud's market share or technology offerings. This aligns with a trend of consolidation in fragmented industries, where stronger players acquire struggling ones to gain scale, technology, or customer bases.

Comparison to Industry Standards

• The acquisition of Medsphere, a company with substantial doubt about its going concern ability and defaulted debt, is not a standard acquisition of a healthy, growing business; it appears to be a distressed asset acquisition.
• The pro forma combined entity's positive GAAP net income and Adjusted EBITDA, despite integrating a financially troubled company, suggests CareCloud's existing operational strength and potential for synergy realization.
• The inclusion of revenue from cancelled contracts in pro forma statements, while disclosed, is a practice that requires careful scrutiny by investors, as it does not reflect ongoing revenue generation.

Corporate Governance

Legal Proceedings

• Medsphere's management is not currently aware of any matters that will have a material adverse effect on the financial position, results of operations or cash flows of the Company.

Related Party Transactions

• Medsphere had a 2020 related-party note payable of $144,046 as of June 30, 2025, with an employee.
• Medsphere had notes receivable from shareholders totaling $924,155 as of December 31, 2024, which were deemed uncollectible and written off against additional paid-in-capital as of June 30, 2025.

Stakeholder Impact

• Shareholders (CareCloud): Potential for increased revenue and market share through acquisitions, but also integration risks and the challenge of absorbing a financially distressed entity. The pro forma positive net income and EBITDA could be seen favorably.
• Shareholders (Medsphere): The company is winding down, and its shareholders' deficit is substantial, indicating significant losses and likely no recovery for equity holders.
• Creditors (Medsphere): The acquisition by CareCloud, including the $8.25 million payment to Wells Fargo, provides some recovery for secured lenders, but the total defaulted debt is much higher. The $10 million in exit fees also impacts the recovery for other creditors.
• Employees (Medsphere): The wind-down of Medsphere implies job losses, though some employees might transition to CareCloud. Transaction and integration costs include severance amounts.
• Customers (Medsphere, RevNu, Mesa): Transition to CareCloud's platform and services. The mention of cancelled contracts prior to acquisition suggests some customer churn or dissatisfaction.

Next Steps

• Medsphere's management anticipates winding down the company before December 31, 2025.
• CareCloud will finalize the purchase price allocations for the acquired companies by year-end, as additional information regarding customer attrition becomes available.
• CareCloud will continue to evaluate the acquired companies' accounting policies during the measurement period (up to one year from acquisition date).

Key Dates

Recommendation

The filing presents a mixed picture. While CareCloud's pro forma financials show positive results post-acquisition, the underlying distress of Medsphere, including its significant debt and planned wind-down, introduces complexity and integration risks. The positive pro forma net income and Adjusted EBITDA are encouraging, but the inclusion of revenue from cancelled contracts and the preliminary nature of purchase price allocations warrant caution. Investors should hold to observe the actual integration process, realization of synergies, and how CareCloud manages the acquired customer base and technology, especially given the distressed nature of the Medsphere acquisition.

Keywords

CareCloud, Medsphere, RevNu, Mesa, Acquisition, Healthcare IT, Pro Forma Financials, Adjusted EBITDA, SEC Filing, 8-K/A, Corporate Acquisition, Financial Reporting, Going Concern, Debt Default